| SPRY Shares Outstanding History Table | ||||||||||||||||||||||||||||
Below is a table of the SPRY shares outstanding history going back to 10/31/2022:
Also see: SPRY Market Cap History SPRY YTD Return |
SPRY Shares Outstanding History — ARS Pharmaceuticals Share Count Over Time
As of 3/4/2026 ARS Pharmaceuticals has 99.30 million SPRY shares outstanding. Investors often track the SPRY shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SPRY share count trends over time, with 13 historical shares outstanding datapoints presented, dating back to 10/31/2022.
| SPRY Shares Outstanding History Chart | |||||||||||||||||||||||||||||
SPRY Historical Shares Outstanding: +35.40% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||
| SPRY Stock Price Chart |
| About ARS Pharmaceuticals Inc |
| ARS Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression. We show 13 historical shares outstanding datapoints in our coverage of SPRY's shares outstanding history. Understanding the changing numbers of SPRY shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SPRY versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SPRY by allowing them to research SPRY shares outstanding history as well as any other stock in our coverage universe. |
| SPRY Current Stock Quote |
Quotes delayed 20 minutes  Free SPRY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SPRY Share Performance |
| Shares Outstanding Peers |
| ARS Pharmaceuticals (SPRY) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SQL Shares Outstanding History SQZ Shares Outstanding History SRDX Shares Outstanding History SRGA Shares Outstanding History SRNE Shares Outstanding History SRPT Shares Outstanding History SRRA Shares Outstanding History SRRK Shares Outstanding History SRTS Shares Outstanding History SRZN Shares Outstanding History More Healthcare companies » |
SPRY Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
